Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Analytics

Trial Phases

No phase data

Trial Status

Other2

Role Distribution

Other Roles2

Activity Timeline

Clinical Trials (2)

Long-term MOno-Antiplatelet Drug Strategy After PerCutanEous CoronAry InterveNtion
Antiplatelet Drug-related Gastrointestinal Injury
StudydirectorStart date: 2018-10-15
REduction of rIsk for Contrast Induced Nephropathy
Contrast Induced Nephropathy
Studydirector

Research Network

Collaboration Network

2 collaborators·1 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

Guangdong Cardiovascular Institute,Guangdong General Hospital

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Shiqun Chen, MS

Guangdong Cardiovascular Institute,Guangdong General Hospital

Related
2 trials

Shared therapeutic areas:

Antiplatelet Drug-related Gastrointestinal InjuryContrast Induced Nephropathy

Worked with same sponsors:

Dongguan Kanghua HospitalDongguan People's Hospital+17 more
Collaborated on 2 trials
Similarity Score28%

Charles Davidson, MD

Northwestern University

Related
3 trials

Shared therapeutic areas:

Contrast Induced Nephropathy
Similarity Score15%

Ebrahim Nematipur, M.D.

Tehran Heart Center

Related
1 trials

Shared therapeutic areas:

Contrast Induced Nephropathy
Similarity Score15%

Hamidreza Purhosseini,, M.D.

Tehran Heart Center

Related
1 trials

Shared therapeutic areas:

Contrast Induced Nephropathy
Similarity Score15%

Roxana Mehran, MD

Icahn School of Medicine at Mount Sinai

Related
9 trials

Shared therapeutic areas:

Contrast Induced Nephropathy
Similarity Score15%

Ahmad Iaminisharif, M.D.

Tehran Heart Center

Related
2 trials

Shared therapeutic areas:

Contrast Induced Nephropathy
Similarity Score15%

Sirus Darabian, M.D.

Tehran Heart Center

Related
2 trials

Shared therapeutic areas:

Contrast Induced Nephropathy
Similarity Score15%

Yingling Zhou, MD

Guangdong Cardiovascular Institute,Guangdong General Hospital

Related
2 trials

Shared therapeutic areas:

Contrast Induced Nephropathy

Worked with same sponsors:

First Affiliated Hospital, Sun Yat-Sen UniversityGuangdong Provincial People's Hospital+3 more
Similarity Score15%

Ali Vasheghani-Farahani, M.D.

Tehran University of Medical Sciences, Tehran Heart Center

Related
1 trials

Shared therapeutic areas:

Contrast Induced Nephropathy
Similarity Score15%

Kianush Hossein, M.D.

Tehran Heart Center

Related
1 trials

Shared therapeutic areas:

Contrast Induced Nephropathy
Similarity Score15%

Publications (0)

No publications found for this investigator.

Clinical Trials (2)

Showing 2 of 2 trials

NCT03725800StudyDirector

Long-term MOno-Antiplatelet Drug Strategy After PerCutanEous CoronAry InterveNtion

Antiplatelet Drug-related Gastrointestinal Injury
Unknown
NCT01402232StudyDirector

REduction of rIsk for Contrast Induced Nephropathy

Contrast Induced Nephropathy
Unknown

All 2 trials loaded